Measures of cardiovascular risk and subclinical atherosclerosis in a cohort of women with a remote history of preeclampsia

Atherosclerosis

Volumn 229, Issue 1, 2013, Pages 234-239

  McDonald, Sarah D ^a   Ray, Joel ^b,c,d   Teo, Koon ^a,b,e   Jung, Hyejung ^e   Salehian, Omid ^a   Yusuf, Salim ^a,e   Lonn, Eva ^a,e  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

Cardiovascular disease; Carotid intima media thickness; Hypertension; Preeclampsia; Pregnancy

Indexed keywords

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMPARATIVE STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FEMALE; HIP CIRCUMFERENCE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PREECLAMPSIA; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MIDDLE AGED; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84879411538     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.04.020     Document Type: Article

References (33)

1. National high blood pressure education Program working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990, 163(5 Pt 1):1691-1712.
2. Ray J.G., Vermeulen M.J., Schull M.J., Redelmeier D.A. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005, 366(9499):1797-1803.
3. McDonald S.D., Malinowski A., Zhou Q., Yusuf S., Devereaux P.J. Cardiovascular sequelae of Preeclampsia/Eclampsia: a systematic review and meta-analyses. Am Heart J 2008, 156(5):918-930.
4. Haukkamaa L., Moilanen L., Kattainen A., et al. Pre-eclampsia is a risk factor of carotid artery atherosclerosis. Cerebrovas Dis 2009, 27(6):599-607.
5. Stein J.H., Korcarz C.E., Hurst R.T., et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. JAm Soc Echocardiogr 2008, 21(2):93-111.
6. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115(4):459-467.
7. Chambless L.E., Heiss G., Folsom A.R. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 1997, 146:483-494.
8. Wu K.K., Folsom A.R., Heiss G., Davis C.E., Conlan M.G., Barnes R. Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early results of the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 1992, 2(4):471-480.
9. Heiss G., Sharrett A.R., Barnes R., Chambless L.E., Szklo M., Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol 1991, 134(3):250-256.
10. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. NEngl J Med 1999, 340(1):14-22.
11. Greenland P., Abrams J., Aurigemma G.P., et al. Prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: writing group III. Circulation 2000, 101(1):E16-E22.
12. Ray J.G., Burrows R.F., Burrows E.A., Vermeulen M.J. MOS HIP: McMaster outcome study of hypertension in pregnancy. Early Hum Dev 2001, 64(2):129-143.
13. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364(9438):937-952.
14. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
15. Lonn E., Yusuf S., Dzavik V., et al. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation 2001, 103(7):919-925.
16. Lonn E.M., Gerstein H.C., Sheridan P., et al. Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone). JAm Coll Cardiol 2009, 53(22):2028-2035.
17. Grewal J., Anand S., Islam S., Lonn E. Prevalence and predictors of subclinical atherosclerosis among asymptomatic "low risk" individuals in a multiethnic population. Atherosclerosis 2008, 197(1):435-442.
18. Inaba Y., Chen J.A., Bergmann S.R. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis 2012, 220(1):128-133.
19. Dogan S., Kastelein J.J., Grobbee D.E., Bots M.L. Mean common or mean maximum carotid intima-media thickness as primary outcome in lipid-modifying intervention studies. JAtheroscler Thromb 2011, 18(11):946-957.
20. McGorrian C., Yusuf S., Islam S., et al. Estimating modifiable coronary heart disease risk in multiple regions of the world: the INTERHEART Modifiable Risk Score. Eur Heart J 2011, 32(5):581-589.
21. McDonald S.D., Han Z., Walsh M.W., Gerstein H.C., Devereaux P.J. Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis 2010, 55(6):1026-1039.
22. Blaauw J., Smit A.J., van Pampus M.G., et al. Skin autofluorescence, a marker of advanced glycation end products and oxidative stress, is increased in recently preeclamptic women. Am J Obstet Gynecol 2006, 195(3):717-722.
23. Berends A.L., de Groot C.J., Sijbrands E.J., et al. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension 2008, 51(4):1034-1041.
24. Gaugler-Senden I.P., Berends A.L., de Groot C.J., Steegers E.A. Severe, very early onset preeclampsia: subsequent pregnancies and future parental cardiovascular health. Eur J Obstet Gynecol Reprod Biol 2008, 140(2):171-177.
25. Forest J.C., Girouard J., Masse J., et al. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol 2005, 105(6):1373-1380.
26. Bellamy L., Casas J.P., Hingorani A.D., Williams D.J. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007, 335(7627):974.
27. Johnsen S.H., Mathiesen E.B. Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep 2009, 11(1):21-27.
28. Al-Shali K., House A.A., Hanley A.J., et al. Differences between carotid wall morphological phenotypes measured by ultrasound in one, two and three dimensions. Atherosclerosis 2005, 178(2):319-325.
29. Conijn M.M., Kloppenborg R.P., Algra A., et al. Cerebral small vessel disease and risk of death, ischemic stroke, and cardiac complications in patients with atherosclerotic disease: the Second Manifestations of ARTerial disease-Magnetic Resonance (SMART-MR) study. Stroke 2011, 42(11):3105-3109.
30. Agewall S., Fagerberg B., Berglund G., Schmidt C., Wendelhag I., Wikstrand J. Multiple risk intervention trial in high risk hypertensive men: comparison of ultrasound intima-media thickness and clinical outcome during 6 years of follow-up. JIntern Med 2001, 249(4):305-314.
31. Coolman M., de Groot C.J., Jaddoe V.W., Hofman A., Raat H., Steegers E.A. Medical record validation of maternally reported history of preeclampsia. JClin Epidemiol 2010, 63(8):932-937.
32. Diehl C.L., Brost B.C., Hogan M.C., et al. Preeclampsia as a risk factor for cardiovascular disease later in life: validation of a preeclampsia questionnaire. Am J Obstet Gynecol 2008, 198(5):e11-e13.
33. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288(3):321-333.